Academic Journals Database
Disseminating quality controlled scientific knowledge

Monoclonal auto-antibodies and sera of autoimmune patients react with Plasmodium falciparum and inhibit its in vitro growth

Author(s): Karima Brahimi | Yuri Chaves Martins | Graziela Maria Zanini | Maria de Fátima Ferreira-da-Cruz | Cláudio Tadeu Daniel-Ribeiro

Journal: Memórias do Instituto Oswaldo Cruz.
ISSN 0074-0276

Volume: 106;
Start page: 44;
Date: 2011;
Original page

Keywords: auto-antibodies | autoimmune diseases | autoimmunity | immune protection | malaria | Plasmodium falciparum

The relationship between autoimmunity and malaria is not well understood. To determine whether autoimmune responses have a protective role during malaria, we studied the pattern of reactivity to plasmodial antigens of sera from 93 patients with 14 different autoimmune diseases (AID) who were not previously exposed to malaria. Sera from patients with 13 different AID reacted against Plasmodium falciparum by indirect fluorescent antibody test with frequencies varying from 33-100%. In addition, sera from 37 AID patients were tested for reactivity against Plasmodium yoelii 17XNL and the asexual blood stage forms of three different P. falciparum strains. In general, the frequency of reactive sera was higher against young trophozoites than schizonts (p < 0.05 for 2 strains), indicating that the antigenic determinants targeted by the tested AID sera might be more highly expressed by the former stage. The ability of monoclonal auto-antibodies (auto-Ab) to inhibit P. falciparum growth in vitro was also tested. Thirteen of the 18 monoclonal auto-Ab tested (72%), but none of the control monoclonal antibodies, inhibited parasite growth, in some cases by greater than 40%. We conclude that autoimmune responses mediated by auto-Ab may present anti-plasmodial activity.
Why do you need a reservation system?      Affiliate Program